SCHEMBL6671884

SCHEMBL6671884

CCC(CS(=O)(=O)N1CCN(c2ncc(-c3ccccn3)cn2)CC1)NC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC6A7 Q99884 1/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
HSD17B10 Q99714 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
TRPV4 Q9HBA0 1/20 0.39
CTSS P25774 3/20 0.38
SMO Q99835 1/20 0.37
LMNA P02545 2/20 0.37
MEN1 O00255 1/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6808747 0.85 SLC6A7 (0.38) SLC6A7KDM4EALDH1A1MAPTSMN1; SMN2
SCHEMBL6647516 0.79 MMP7 (0.44) SLC6A7KDM4EALDH1A1MAPTHSD17B10
SCHEMBL6671345 0.78 MMP7 (0.51) SLC6A7KDM4EALDH1A1MAPTHSD17B10
SCHEMBL6807758 0.77 SLC6A7 (0.38) SLC6A7KDM4EALDH1A1MAPTHSD17B10
SCHEMBL6800839 0.76 CYP3A4 (0.38) SLC6A7KDM4EALDH1A1SMN1; SMN2CTSS
SCHEMBL6644515 0.75 MMP7 (0.46) SLC6A7KDM4EALDH1A1MAPTSMN1; SMN2
SCHEMBL6806502 0.75 SLC6A7 (0.41) SLC6A7KDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL6673023 0.75 SLC6A7 (0.41) SLC6A7KDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL6644984 0.75 LMNA (0.66) SLC6A7KDM4EALDH1A1MAPTHSD17B10
SCHEMBL6811956 0.74 CYP3A4 (0.42) SLC6A7KDM4EALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1417181-A1 ARYLPIPERAZINES AND ARYLPIPERIDINES AND THEIR USE AS METALLOPROTEINASE INHIBITING AGENTS AstraZeneca AB (SE) 2004-05-12 EP claimed
WO-2003014092-A1 ARYLPIPERAZINES AND ARYLPIPERIDINES AND THEIR USE AS METALLOPROTEINASE INHIBITING AGENTS ASTRAZENECA AB (SE) 2003-02-20 WO claimed